{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:22:23Z","timestamp":1792318943339,"version":"4.4.0"},"reference-count":53,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.3892\/ijo.2013.1835","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T09:53:26Z","timestamp":1361440406000},"page":"1219-1228","source":"Crossref","is-referenced-by-count":53,"title":["DFMO\/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma"],"prefix":"10.3892","volume":"42","author":[{"given":"DANA-LYNN T.","family":"KOOMOA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIRK","family":"GEERTS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"INGO","family":"LANGE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"KOSTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTHONY E.","family":"PEGG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID J.","family":"FEITH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDR\u00c9 S.","family":"BACHMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"key20180107180931_b1-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"key20180107180931_b2-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107180931_b3-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(03)01166-5","article-title":"Neuroblastoma: biology and molecular and chromosomal pathology","volume":"4","author":"Schwab","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20180107180931_b4-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107180931_b5-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","article-title":"Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience","volume":"27","author":"Canete","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107180931_b6-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2008.17.5877","article-title":"Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification","volume":"27","author":"De Bernardi","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107180931_b7-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1038\/sj.onc.1210938","article-title":"Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo","volume":"27","author":"Johnsen","year":"2008","journal-title":"Oncogene"},{"key":"key20180107180931_b8-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2008.12.005","article-title":"Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma","volume":"15","author":"Otto","year":"2009","journal-title":"Cancer Cell"},{"key":"key20180107180931_b9-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/sj.onc.1211017","article-title":"N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells","volume":"27","author":"Ushmorov","year":"2008","journal-title":"Oncogene"},{"key":"key20180107180931_b10-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1208808","article-title":"Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells","volume":"24","author":"Wallick","year":"2005","journal-title":"Oncogene"},{"key":"key20180107180931_b11-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1158\/0008-5472.CAN-08-1865","article-title":"Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt\/protein kinase B and p27Kip1 in neuroblastoma","volume":"68","author":"Koomoa","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107180931_b12-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/bcr277","article-title":"The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer","volume":"3","author":"Chiarle","year":"2001","journal-title":"Breast Cancer Res"},{"key":"key20180107180931_b13-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107180931_b14-ijo-42-04-1219","first-page":"3381","article-title":"Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer","volume":"57","author":"Esposito","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107180931_b15-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3858\/emm.2009.41.11.102","article-title":"The function of p27Kip1 during tumor development","volume":"41","author":"Lee","year":"2009","journal-title":"Exp Mol Med"},{"key":"key20180107180931_b16-ijo-42-04-1219","first-page":"5244","article-title":"Loss of p27Kip1 from cyclin E\/cyclin-dependent kinase (CDK) 2 but not from cyclin D1\/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes","volume":"60","author":"Ravanko","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107180931_b17-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","article-title":"p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion","volume":"7","author":"Baldassarre","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180107180931_b18-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.M609944200","article-title":"The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex","volume":"282","author":"Itoh","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107180931_b19-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1158\/0008-5472.CAN-06-1596","article-title":"Cyclin D1 induction of cellular migration requires p27(Kip1)","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107180931_b20-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/MCB.23.1.216-228.2003","article-title":"Novel p27(Kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions","volume":"23","author":"McAllister","year":"2003","journal-title":"Mol Cell Biol"},{"key":"key20180107180931_b21-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4161\/cc.9.8.11259","article-title":"p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo","volume":"9","author":"See","year":"2010","journal-title":"Cell Cycle"},{"key":"key20180107180931_b22-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.surg.2005.03.023","article-title":"Opposing roles for p21(waf1\/cip1) and p27(Kip1) in enterocyte differentiation, proliferation, and migration","volume":"138","author":"Stehr","year":"2005","journal-title":"Surgery"},{"key":"key20180107180931_b23-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.103.24.2967","article-title":"Role for p27(Kip1) in vascular smooth muscle cell migration","volume":"103","author":"Sun","year":"2001","journal-title":"Circulation"},{"key":"key20180107180931_b24-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4161\/cc.9.11.11927","article-title":"Regulation of cell migration by mTOR is mediated through changes in p27(Kip1) phosphorylation","volume":"9","author":"Woods","year":"2010","journal-title":"Cell Cycle"},{"key":"key20180107180931_b25-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1534-5807(04)00103-0","article-title":"Stopping and going with p27Kip1","volume":"6","author":"Assoian","year":"2004","journal-title":"Dev Cell"},{"key":"key20180107180931_b26-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1185504","article-title":"p27Kip1 modulates cell migration through the regulation of RhoA activation","volume":"18","author":"Besson","year":"2004","journal-title":"Genes Dev"},{"key":"key20180107180931_b27-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.4161\/cc.8.21.9789","article-title":"p27 as Jekyll and Hyde: regulation of cell cycle and cell motility","volume":"8","author":"Larrea","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180107180931_b28-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tcb.2005.05.008","article-title":"p27(Kip1) and stathmin share the stage for the first time","volume":"15","author":"Iancu-Rubin","year":"2005","journal-title":"Trends Cell Biol"},{"key":"key20180107180931_b29-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1158\/0008-5472.CAN-07-1375","article-title":"Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma","volume":"67","author":"Denicourt","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107180931_b30-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1038\/sj.emboj.7601388","article-title":"C-terminal phosphorylation controls the stability and function of p27Kip1","volume":"25","author":"Kossatz","year":"2006","journal-title":"EMBO J"},{"key":"key20180107180931_b31-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1101\/gad.1583207","article-title":"Duality of p27Kip1 function in tumorigenesis","volume":"21","author":"Sicinski","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107180931_b32-ijo-42-04-1219","first-page":"527","article-title":"Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line","volume":"10","author":"Supriatno","year":"2003","journal-title":"Oncol Rep"},{"key":"key20180107180931_b33-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000152939","article-title":"p27Kip1 promotes migration of metastatic hepatocellular carcinoma cells","volume":"29","author":"Wang","year":"2008","journal-title":"Tumour Biol"},{"key":"key20180107180931_b34-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.25074","article-title":"The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification","volume":"126","author":"Geerts","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107180931_b35-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/1535-7163.MCT-08-1217","article-title":"Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt\/protein kinase B regulation and apoptosis in neuroblastoma","volume":"8","author":"Koomoa","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107180931_b36-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.yexcr.2007.12.008","article-title":"The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma","volume":"314","author":"Revet","year":"2008","journal-title":"Exp Cell Res"},{"key":"key20180107180931_b37-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)62295-X","article-title":"Complex regulation of the cyclin-dependent kinase inhibitor p27Kip1 in thyroid cancer cells by the PI3K\/AKT pathway: regulation of p27Kip1 expression and localization","volume":"166","author":"Motti","year":"2005","journal-title":"Am J Pathol"},{"key":"key20180107180931_b38-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4161\/cc.3.8.1073","article-title":"Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27Kip1 in breast cancer","volume":"3","author":"Motti","year":"2004","journal-title":"Cell Cycle"},{"key":"key20180107180931_b39-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1074\/jbc.273.21.13150","article-title":"Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB","volume":"273","author":"van Weeren","year":"1998","journal-title":"J Biol Chem"},{"key":"key20180107180931_b40-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0215(20010520)95:3<176::AID-IJC1030>3.0.CO;2-Z","article-title":"Expression of P27(Kip1) is prognostic and independent of MYCN amplification in human neuroblastoma","volume":"95","author":"Bergmann","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107180931_b41-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/14728222.2011.561318","article-title":"Targeting p27(Kip1) protein: its relevance in the therapy of human cancer","volume":"15","author":"Borriello","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107180931_b42-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"R819","DOI":"10.1186\/bcr1292","article-title":"Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment","volume":"7","author":"Richert","year":"2005","journal-title":"Breast Cancer Res"},{"key":"key20180107180931_b43-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1024055522067","article-title":"Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice","volume":"20","author":"Manni","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"key20180107180931_b44-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-006-9432-4","article-title":"Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells","volume":"105","author":"Jun","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107180931_b45-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/carcin\/15.4.647","article-title":"Effects on tumor induction, growth, metastasis and histology of concurrent administration of putrescine and its metabolizing inhibitor alpha-difluoromethylornithine in nickel tumorigenesis in soft tissue","volume":"15","author":"Ohmori","year":"1994","journal-title":"Carcinogenesis"},{"key":"key20180107180931_b46-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF01753670","article-title":"alpha-Difluoromethylornithine inhibits liver metastasis produced by intrasplenic injection of human tumor cells into nude mice","volume":"7","author":"Zirvi","year":"1989","journal-title":"Clin Exp Metastasis"},{"key":"key20180107180931_b47-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910390220","article-title":"Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo","volume":"39","author":"Kubota","year":"1987","journal-title":"Int J Cancer"},{"key":"key20180107180931_b48-ijo-42-04-1219","first-page":"933","article-title":"Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice","volume":"47","author":"Sunkara","year":"1987","journal-title":"Cancer Res"},{"key":"key20180107180931_b49-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00179593","article-title":"A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma","volume":"4","author":"Meyskens","year":"1986","journal-title":"Invest New Drugs"},{"key":"key20180107180931_b50-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1768-322X.1985.tb00352.x","article-title":"Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice","volume":"53","author":"Klein","year":"1985","journal-title":"Biol Cell"},{"key":"key20180107180931_b51-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1158\/1078-0432.CCR-04-2071","article-title":"Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest","volume":"11","author":"Yaari","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107180931_b52-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1158\/0008-5472.CAN-07-6866","article-title":"ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma","volume":"68","author":"Hogarty","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107180931_b53-ijo-42-04-1219","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/0008-5472.CAN-08-2968","article-title":"Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma","volume":"69","author":"Rounbehler","year":"2009","journal-title":"Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1835\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:25:44Z","timestamp":1714987544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,2,21]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.3892\/ijo.2013.1835"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1835","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}